Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | -0.99% | -9.09% | -83.90% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.90% | 141M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- RAPT Therapeutics Starts Mid-Stage Trial in Moderate-to-Severe Asthma